Company: ZVRA
Filing Date: 2025-03-31
Form Type: PREC14A
Source: 0001193125-25-068746
Chunk: 59

Company: ZEVRA THERAPEUTICS, INC.
Filing Date: 2025-03-31
Form: PREC14A
Chunk 59
---
 of 30.0%), the corporate targets were achieved at 125% of target (weighted total of 25.0%), and the bonus enhancement target was achieved at 32.9% of target (weighted total of 32.9%). The actual amounts paid to our NEOs under our 2024 annual cash bonus program are set forth in the 2024 Summary Compensation Table below. Our Compensation Committee periodically reviews NEO target bonus amounts in consultation with management and the committee’s compensation consultant to determine whether any adjustments are necessary or appropriate. The NEOs’ 2025 target annual cash bonus opportunities are unchanged from 2024. Long-TermIncentive Compensation Our Amended and Restated 2014 Equity Incentive Plan (the “2014 Plan”) and our 2023 Employment Inducement Award Plan (the “2023 Plan”) authorize us to make grants to eligible recipients of stock options, restricted stock units and other stock-basedawards. All of our awards granted in 2024 under these plans were in the form of stock options and restricted stock units. We typically grant stock options at the start of employment to each executive and our other employees. Additionally, the Compensation Committee may grant additional equity in its discretion to provide additional targeted grants in appropriate circumstances, such as in connection with an employee taking on a new role at the Company. Typically, our stock options vest in equal annual installments over a period of four years, subject to continued service, and our restricted stock units vest in equal annual installments over a period of three years, subject to continued service. However, our Compensation Committee may, from time to time, construct alternate vesting schedules as it determines are appropriate to motivate particular employees. Additionally, stock options and restricted stock units granted to our employees may be subject to accelerated vesting in certain circumstances, as described below in the section titled “Employment Arrangements and Potential Payments upon Termination of Employment.” For employees who are not officers of the Company, we generally award stock options and restricted stock units on the date the single-member non-officerstock 57

award subcommittee of the Compensation Committee (the “Option Committee”) approves the grant. In 2015, the Compensation Committee formed this Option Committee, currently composed of our Chief Executive Officer, to which it delegated authority to grant, without any further action required by the Compensation Committee, stock awards to employees who are not officers of the Company, provided that such grants are made in accordance with guidelines established by the Compensation Committee. If employees are